AI Is Accelerating Healthcare Transformation

Cancer is the Epidemic of our TimeThe disease is deeply personal to every one of us because someone we know has likely battled it.

Leading to the creation of one of the most important Initiatives …

What is Cancer Moonshot?

On January 2016, the White House announced its aim to deliver a decade’s worth of advances in cancer prevention, diagnosis, and treatment, in five years with this initiative.

This initiative includes the building of an AI framework named CANDLE (Cancer Distributed Learning Environment) being developed by multiple organizations.It will help us change the way we understand cancer.

READ MORE

“GPU Deep Learning has given us a new tool to tackle grand challenges that have, up to now, been too complex for even the most powerful supercomputers. Together with the Department of Energy and the National Cancer Institute we are creating an AI supercomputing platform for cancer research.”

- Jen-Hsun HuangCEO at NVIDIA

SC16READ MORE

“Big Data and Computing Power together provide the

possibility of significant insight into how genomics, family medical history, lifestyles,

genetic changes can trigger cancer and how the cancers

can be treated.” - Joe Biden

Vice President of the United States

CIO InterviewREAD MORE

The bright future of AI in healthcare only continues to become more and more prominent …

EnliticImaging &

Diagnostics

Insilico Medicine

Drug Discovery

Pathway GenomicsImaging &

Diagnostics

READ MORE

“Let's say a patient gets a lung CT screening. Enlitic's software could "read" the CT scan and determine the probability that the patient has lung cancer, find clinically similar patients, and show their treatments and outcomes. The clinician could use this information to decide whether or not to perform a biopsy. By immediately giving the clinician the most accurate information, the patient is less likely to have a missed diagnosis or an unneeded biopsy.”

Enlitic applies the state of the art in deep learning technology to medicine.

- Jeremy HowardFounder and CEO of Enlitic

IDG Connect Interview

“At Insilico we are working on a system to discover candidates and repurposing candidates that are most efficacious and least toxic to specific diseases and looking for new approaches to treat individual patients with rare diseases.

- Alex ZharvoronkovCEO at Insilico Medicine

RE-WORK Interview

Insilico Medicine applies Deep Learning algorithms to drug discovery for various applications .

“We are in the process of initiating additional disease specific studies for early cancer detection in high risk patients, including a study in lung cancer, and will present and publish the data in the appropriate forums.””

- Glenn BraunsteinChief Medical Officer at Pathway

GenomicsPress Release

Pathway Genomics developed blood test kit, CencerIntercept Detect, with IBM Watson to test early

cancer detection.

LEARN MORE ABOUT HOW THE WORLD OF HEALTHCARE IS BEING TRANSFORMED BY AI

LEARN MORE